GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer

Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of total lung cancers; 40% to 60% of NSCLC patients die of cancer recurrence after cancer resection. Since GLK (also named MAP4K3) induces activation of NF-κB, which contributes to tumor p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Hsu, Chung-Ping, Chuang, Huai-Chia, Lee, Ming-Ching, Tsou, Hsiao-Hui, Lee, Li-Wen, Li, Ju-Pi, Tan, Tse-Hua
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173093/
https://ncbi.nlm.nih.gov/pubmed/27203390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados